British Journal of Haematology

Anti-PF4 disorders: Pathogenesis, diagnosis and treatment buff.ly/hlPEh30

ZIP10 as a potential therapeutic target in acute myeloid leukaemia buff.ly/WGtRCzF

CCR5 predicts neurotoxicity in CAR-T-cell therapy buff.ly/7zLt4E2

Large-cell transformation of mycosis fungoides: Patterns of care and patient outcomes buff.ly/8FzzAKw

Iron overload and morbidities in Chinese with non-transfusion-dependent thalassaemia buff.ly/ZRCrn0Q

Frail is not fail: Limited impact of comorbidities on non-relapse mortality and safety in patients with LBCL treated with CAR-T buff.ly/7a2gj66

Subjects with primary myelofibrosis and elevated haemoglobin levels at diagnosis tend to have longer survival rates than those with normal or reduced haemoglobin levels. buff.ly/GV1MBr4

Lamotrigine and anti-seizure medications in HLH: A systematic review buff.ly/s1N7CNS

Prevalence of myeloid gene alterations in paediatric cutaneous and systemic mastocytosis buff.ly/DkRUxUm

Can we identify individuals at risk to develop multiple myeloma? A machine learning-based predictive model buff.ly/MaqR0fP

Simplified Molecular International Prognostic Index as an eligibility criterion for clinical trials: Analysis of the Turkish Lymphoma Study Group's large B-cell lymphoma cohort buff.ly/uF9jtm7

Magrolimab, an anti-CD47 antibody, combined with obinutuzumab and venetoclax, is safe and induces durable responses in relapsed/refractory indolent B-cell lymphomas. @Rlakhotia102 @RoschewskiMD @MelanicjMD buff.ly/xXzEhOI

Hot off the press!! 😁 Large-cell transformation of #MycosisFungoides Published in @BrJHaem Open access➡️doi.org/10.1111/bjh.20… Congrats & 🙏to Dr Martin Higgins & Dr Pippa Johnstone, 2 super⭐️ former #radonc cutaneous lymphoma fellows at @PeterMacCC & joint first authors👏

Anti-thymocyte globulin in immune-mediated cytopenias: A monocentric experience and literature review buff.ly/HiCotLe

📣📚 #MeetTheEditor Episode 9: We're excited to introduce you our #AssociateEditor Toby Eyre! Stay tuned! #BrJHaem #Haematology @wileyOnc_Hem @BritSocHaem

Largest UK study on AHSCT in MS reports on safety and sustained efficacy of the procedure and highlights uneven geographical access across the country. #AHSCT #MS #autoimmunity #research #therapy buff.ly/izjtjpE

A phase II trial by @FIL_ETS investigating copanlisib+BR in R/R DLBCL showed limited efficacy. More effective strategies are needed for this challenging population. Clinical research never stops! buff.ly/bXqlq7H @mattia_novo

A recent study shows uneven adoption of electronic blood transfusion systems in NHS England, with barriers such as funding and integration. Economic evaluations are crucial to support implementation. buff.ly/aogCWfh

NGS-based chimerism testing shows improved sensitivity in post-HCT monitoring compared to STR. Real-world data from a single-center study buff.ly/V1Shjlj

Hypoxia in pregnancy and unscheduled Caesarean deliveries are linked with worse immediate postpartum outcomes in sickle cell disease. buff.ly/XGWaNwZ @CaptainAV @SinaiHemeOB